Skip to main content
. 2022 Mar 31;13:846248. doi: 10.3389/fimmu.2022.846248

Figure 4.

Figure 4

CD4+ T-cell responses in healthy controls and RMD patients receiving different types of vaccines upon S/M/N peptide (A, C, E) or polyclonal (B, D, F) stimulation. HC, healthy controls; RMD, rheumatic and musculoskeletal disease. (A) a vs. BBIBP-CorV (RMD) (p = 0.0316). (D) a vs. BBIBP-CorV (RMD) (p = 0.0047). (E) a vs. BNT162b2 (RMD) (p = 0.011).